Skip to main content
LGVN logo

Longeveron Inc. (LGVN)

LGVNNASDAQHealthcareBiotechnology

$1.66Today:−$0.09 (−5.21%)1Y +203.33%

As of Nov 20, 2026 close

Market cap
$5.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.48$8.90
Volume (live)
-
Avg. volume (3M)
90.25K

Longeveron (LGVN) Key Statistics & Financial Metrics

Longeveron has a $5.84M market cap and a −1921.7% TTM net margin as of the Nov 20, 2026 close. Valuation, profitability, balance sheet, dividend and growth figures below.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Stock Price

Current price, 52-week range, and moving averages

Current Price$1.66
1-Day Change−5.21%
52-Week High$8.90
52-Week Low$0.48
YTD Change+206.91%
1-Year Change+203.33%
50-Day MA$2.44
200-Day MA$3.60
Avg Volume (30 day)90.25K

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Growth Rates (YoY)

Year-over-year growth metrics

Revenue Growth−18.93%

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Source: Market prices and company fundamentals from financial filings. Data as of Nov 20, 2026. Data sources and methodology

Frequently Asked Questions About Longeveron Statistics

Is LGVN stock overvalued?

As of the Nov 20, 2026 close, Longeveron (LGVN) trades at 5.0x TTM sales and 0.0x EV/EBITDA.

How much debt does LGVN have?

As of its most recent quarterly balance sheet, Longeveron (LGVN) has $581.00K of total debt and $7.25M in cash and securities, a net cash position of $6.66M. Debt-to-equity is 0.12, the current ratio is 1.25 and the quick ratio is 1.25.

How profitable is LGVN?

Over the trailing twelve months Longeveron (LGVN) lost $22.39M on revenue of $1.17M, with a gross margin of 66.4%, an operating margin of −2020.8%, a net margin of −1921.7% and a free cash flow margin of −1567.3%. On the same TTM basis, return on equity is −475.3%, return on invested capital is −2045.2% and return on assets is −186.3%.

How fast is LGVN growing?

Comparing the trailing twelve months with the twelve months before, Longeveron (LGVN)'s revenue fell 18.9%.

Compare these multiples with other companies in the Healthcare sector.